| Novartis Pharma Schweiz AG - Exforge HCT 10 mg/160 mg/12.5 mg, Filmtabletten | | 59407 | | 02 | | Exforge HCT 10 mg/160 mg/12.5 mg | | Filmtabletten | | C09DX01 | | | | 16.09.2009 | | |
| | Composition | | amlodipinum 10 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Amlodipine | 10 mg | | Hydrochlorothiazide | 12.5 mg | | Valsartan | 160 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Amlodipine | 10 mg | | Hydrochlorothiazide | 12.5 mg | | Valsartan | 160 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | | | | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 007 | 28 Comprimé(s) | 21.99 | 39.95 | B | LS | Oui | | 009 | 98 Comprimé(s) | 76.88 | 98.65 | B | LS | Oui |
|
|
